BGICC 2025: Hear from Global Oncology Leaders

The 17th BGICC 2025 (Breast, Gynecological and Immuno-oncology International Cancer Conference) will be held from January 23-24, 2025, at the Hilton Heliopolis Hotel in Cairo, Egypt.

Recognized as the largest and most prestigious oncology conference in Africa and the Middle East, BGICC brings together oncology professionals, researchers, and clinicians to share advancements in breast cancer, gynecological oncology, and immuno-oncology.

The conference will feature lectures, workshops, and specialized courses. BGICC 2025 offers an opportunity to explore the latest research, treatment protocols, and emerging therapies in cancer care, while fostering collaboration and networking among oncology leaders.

BGICC 2025 Conference has received official endorsement from some of the most prestigious organizations in the field of oncology:

European Society of Surgical Oncology (ESSO)

The European Society of Surgical Oncology (ESSO) is a professional organization established in 1981. Its primary mission is to advance the science and practice of cancer surgery for the benefit of patients through education, research, and innovation. The society aims to unify the surgical oncology community and advocate for the importance of surgical oncology in cancer treatment.

European School of Oncology (ESO)

The European School of Oncology (ESO) is an independent non-profit organization committed to providing quality education and training in oncology to ensure all patients receive competent cancer care.

Founded in 1982 by Umberto Veronesi and Laudomia Del Drago, ESO focuses on reducing cancer deaths through early diagnosis and effective treatment. Today, it continues this mission by offering extensive learning programs that address educational gaps both geographically and scientifically, improving cancer care worldwide.

“This endorsement reflects the global recognition of BGICC as a platform for advancing cancer care, fostering collaboration, and sharing groundbreaking research.”

European Society of Gynaecological Oncology (ESGO)

The European Society of Gynaecological Oncology (ESGO) is a leading organization advancing research, education, and clinical practice in gynecological oncology. It unites experts to improve the prevention, diagnosis, and treatment of cancers such as ovarian, uterine, and cervical. ESGO promotes high-quality care, fosters innovation, and provides specialized training through fellowships, workshops, and certification programs.

“This endorsement marks a monumental milestone, highlighting the global collaboration and scientific excellence that BGICC represents. Together, we strive to advance the frontiers of cancer research and care under the unifying theme “One World, One Fight.””

American Society of Clinical Oncology (ASCO)

The American Society of Clinical Oncology (ASCO) was founded in 1964 by seven cancer physicians to improve cancer care during a time when the disease was largely incurable and poorly understood. Over the past five decades, ASCO has grown to over 50,000 members and has played a pivotal role in advancing modern clinical oncology. National cancer research funding has increased significantly, the number of cancer treatments has expanded to over 170, and patient outcomes have improved dramatically.

“This remarkable partnership reflects our shared commitment to innovation, collaboration, and excellence in the fight against cancer. Together, we are bridging borders and uniting efforts under the theme “One World, One Fight” to pave the way for transformative breakthroughs.”

ETOP (European Thoracic Oncology Platform)

ETOP (European Thoracic Oncology Platform) was founded in 2009 as a non-profit organization to improve academic research in thoracic cancers across Europe. It has since become a leading foundation for international clinical and translational studies. IBCSG (International Breast Cancer Study Group) began in 1977 as the “Ludwig Breast Cancer Study Group.”

After transitioning to a focus on laboratory research in 1985, it became a legally recognized non-profit foundation in 1992. IBCSG is known for pioneering studies in breast cancer treatment and improving patient quality of life.On July 1, 2021, ETOP and IBCSG merged to form the ETOP IBCSG Partners Foundation, strengthening their collaborative efforts and enhancing their global research capabilities.

“This prestigious collaboration highlights the conference’s commitment to excellence, innovation, and impactful discussions in the fight against cancer.”

OncoDaily

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.

“BGICC is honored to be endorsed by OncoDaily, a leading global resource in oncology updates and insights.

This partnership reinforces BGICC’s mission to deliver groundbreaking knowledge and foster impactful discussions in the fight against cancer. Together, we’re making strides for a healthier world.”

Faculty of Medicine Ain Shams Research Institute (MASRI)

The Faculty of Medicine Ain Shams Research Institute (MASRI) is equipped with advanced laboratory technology that supports basic science research. The institute aims to be a leading center for scientific research in Egypt and the surrounding region, collaborating with various faculties and universities to enhance medical and biomedical research.

MASRI comprises six departments focused on pre-clinical research, genome studies, and stem cell research, along with an accredited clinical research center. It has established the largest cancer biobank in the Arab region, which contains samples and clinical data from approximately 28,000 patients. This initiative aims to facilitate personalized medicine by understanding the genetic characteristics of Egyptian cancer patients.

“This endorsement highlights the event’s significance as a global platform for advancing cancer research, treatment, and patient care. Together, we aim to reshape the future of oncology with groundbreaking insights and innovations.”

International Gynecologic Cancer Society (IGCS)

Established in 1987 as a non-profit organization, the International Gynecologic Cancer Society (IGCS) unites a diverse group of professionals involved in gynecologic cancer care, including gynecologic oncologists, radiation oncologists, medical oncologists, pathologists, and allied health providers. The mission of IGCS is to enhance the care of individuals affected by gynecologic cancers worldwide through education, training, and public awareness.

The society achieves this by collaborating with regional and international organizations, hosting scientific meetings, promoting research, and conducting outreach activities that raise awareness about early detection and treatment. In 2018, IGCS launched the International Gynecologic Patient Advocacy Network (IGCAN) to support patient outreach and advocacy initiatives aimed at improving the lives of those affected by gynecologic cancers globally.

“This global recognition underscores the conference’s pivotal role in advancing research, education, and collaboration in gynecologic oncology. Together, we unite the world’s experts in the fight against cancer.”

Mark your calendars! Stay tuned for more updates.

𝐃𝐚𝐭𝐞𝐬: January 23-24, 2025
𝐕𝐞𝐧𝐮𝐞: Hilton Cairo Heliopolis

𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐍𝐨𝐰.